首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma
【24h】

Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma

机译:F box only蛋白8的下表达与人脑胶质瘤的肿瘤分级和不良预后有关

获取原文
           

摘要

F box only protein 8 (FBX8) is a novel component of F-box proteins which involved in the ubiquitin-dependent proteolytic pathway. Recent studies have revealed that FBX8 was unregulated in tumor cells and was closely associated with tumor progression and metastasis of other cancer, but little research has been done yet to test its usefulness as a prognostic marker in human glioma. In the present study, we investigated the expression of FBX8 in glioma tissues using immunohistochemical analysis and evaluated its prognostic significance in glioma. We found that 44/77 (57.14%) gilomas had positive expression of FBX8, while 65/77 (84.42%) normal brain tissue had positive expression of FBX8. The expression level of FBX8 was remarkably down-regulated in glioma tissues compared with normal brain tissues (P < 0.001). The down-expression of FBX8 in tumor cells was strongly correlated with tumor grade of patients with glioma (P < 0.05). Patients with lower expression of FBX8 protein had shorter overall survival time than those with higher level expression of FBX8 (P < 0.05). Multivariate analysis showed that FBX8 down-expression was an independent prognostic indicator for glioma patient’s survival. Our results suggest that a potential application of FBX8 in prognosis prediction and therapeutic application in glioma.
机译:仅F-box蛋白8(FBX8)是F-box蛋白的新成分,其参与泛素依赖性蛋白水解途径。最近的研究表明,FBX8在肿瘤细胞中不受调控,并且与其他癌症的肿瘤进展和转移密切相关,但是尚未进行任何研究来测试其作为人类神经胶质瘤预后标志物的作用。在本研究中,我们使用免疫组织化学方法研究了FBX8在神经胶质瘤组织中的表达,并评估了其在神经胶质瘤中的预后意义。我们发现44/77(57.14%)的吉洛玛氏瘤阳性表达FBX8,而65/77(84.42%)的正常脑组织FBX8阳性表达。与正常脑组织相比,神经胶质瘤组织中FBX8的表达水平显着下调(P <0.001)。胶质瘤患者肿瘤细胞中FBX8的表达下调与肿瘤分级密切相关(P <0.05)。 FBX8蛋白表达较低的患者的总生存时间短于FBX8蛋白表达较高的患者(P <0.05)。多因素分析表明,FBX8的下调是神经胶质瘤患者生存的独立预后指标。我们的结果表明,FBX8在神经胶质瘤的预后预测和治疗中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号